Dr. Aseem Malhotra
👤 PersonAppearances Over Time
Podcast Appearances
When we talk about making America healthy again, and this is absolute fact, most drugs, a large proportion for most of the health expenditure in the US comes from prescription drugs for chronic disease management. Chronic disease management are things like heart disease, high blood pressure, type 2 diabetes, for example, so-called high cholesterol we talked about already.
When we talk about making America healthy again, and this is absolute fact, most drugs, a large proportion for most of the health expenditure in the US comes from prescription drugs for chronic disease management. Chronic disease management are things like heart disease, high blood pressure, type 2 diabetes, for example, so-called high cholesterol we talked about already.
Most people taking those drugs are not going to get any benefit Because this is another shift in the paradigm, in the conversations that happens between doctors and patients. We talked about statins, for example, that the benefit at best from taking a statin and preventing a heart attack, people who have not already had a heart attack, which is most people taking statins, is 1%, 1 in 100.
Most people taking those drugs are not going to get any benefit Because this is another shift in the paradigm, in the conversations that happens between doctors and patients. We talked about statins, for example, that the benefit at best from taking a statin and preventing a heart attack, people who have not already had a heart attack, which is most people taking statins, is 1%, 1 in 100.
Most people taking those drugs are not going to get any benefit Because this is another shift in the paradigm, in the conversations that happens between doctors and patients. We talked about statins, for example, that the benefit at best from taking a statin and preventing a heart attack, people who have not already had a heart attack, which is most people taking statins, is 1%, 1 in 100.
Patients are not told that. They're not given an informed choice. But they're all then exposed to side effects. But the good news is, Megan, once this information becomes freely available and these conversations start happening, we can very quickly improve the system. We can get a more efficient healthcare system. We can reduce costs and improve quality as well at the same time.
Patients are not told that. They're not given an informed choice. But they're all then exposed to side effects. But the good news is, Megan, once this information becomes freely available and these conversations start happening, we can very quickly improve the system. We can get a more efficient healthcare system. We can reduce costs and improve quality as well at the same time.
Patients are not told that. They're not given an informed choice. But they're all then exposed to side effects. But the good news is, Megan, once this information becomes freely available and these conversations start happening, we can very quickly improve the system. We can get a more efficient healthcare system. We can reduce costs and improve quality as well at the same time.
Yeah, I know I get that.
Yeah, I know I get that.
Yeah, I know I get that.
And to be fair to Casey as well, I mean, I'm in a very unique position when it comes to the cholesterol discussion because I probably, I'm not blowing my own trumpet here, as an independent doctor, as a cardiologist that doesn't have any link to industry, I've probably done more research and publications and deep dive and understanding of this cholesterol and statin issue than anyone in the world.
And to be fair to Casey as well, I mean, I'm in a very unique position when it comes to the cholesterol discussion because I probably, I'm not blowing my own trumpet here, as an independent doctor, as a cardiologist that doesn't have any link to industry, I've probably done more research and publications and deep dive and understanding of this cholesterol and statin issue than anyone in the world.
And to be fair to Casey as well, I mean, I'm in a very unique position when it comes to the cholesterol discussion because I probably, I'm not blowing my own trumpet here, as an independent doctor, as a cardiologist that doesn't have any link to industry, I've probably done more research and publications and deep dive and understanding of this cholesterol and statin issue than anyone in the world.
And the reality is that once you correct for what we call triglycerides and HDL, you know, parts of the cholesterol profile essentially links to excess body fat and insulin resistance, you know, driven by ultra processed food. There is no relationship with LDL cholesterol and development of heart disease.
And the reality is that once you correct for what we call triglycerides and HDL, you know, parts of the cholesterol profile essentially links to excess body fat and insulin resistance, you know, driven by ultra processed food. There is no relationship with LDL cholesterol and development of heart disease.
And the reality is that once you correct for what we call triglycerides and HDL, you know, parts of the cholesterol profile essentially links to excess body fat and insulin resistance, you know, driven by ultra processed food. There is no relationship with LDL cholesterol and development of heart disease.
That data was actually already available years ago, you know, at the end of the late nineties, the co-director of the Framingham study, which is where cholesterol emerges, a so-called risk factor for heart disease said that if your LDL cholesterol essentially, you know, was below
That data was actually already available years ago, you know, at the end of the late nineties, the co-director of the Framingham study, which is where cholesterol emerges, a so-called risk factor for heart disease said that if your LDL cholesterol essentially, you know, was below
That data was actually already available years ago, you know, at the end of the late nineties, the co-director of the Framingham study, which is where cholesterol emerges, a so-called risk factor for heart disease said that if your LDL cholesterol essentially, you know, was below